Serologic immunogenicity and safety of Herpes Zoster subunit vaccine in patients with Rheumatoid Arthritis receiving Janus Kinase inhibitors.

Källmark, Hanna; Bergström, Tomas; Nagel, Johanna; Gullstrand, Birgitta; Einarsson, Jon T; Bengtsson, Anders A; Kapetanovic, Meliha C

Källmark, Hanna; Bergström, Tomas; Nagel, Johanna; Gullstrand, Birgitta; Einarsson, Jon T; Bengtsson, Anders A; Kapetanovic, Meliha C.

Afiliación

Källmark H; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skåne University Hospital, Lund and Malmö, Sweden.
Bergström T; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Nagel J; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skåne University Hospital, Lund and Malmö, Sweden.
Gullstrand B; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skåne University Hospital, Lund and Malmö, Sweden.
Einarsson JT; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skåne University Hospital, Lund and Malmö, Sweden.
Bengtsson AA; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skåne University Hospital, Lund and Malmö, Sweden.
Kapetanovic MC; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University and Skåne University Hospital, Lund and Malmö, Sweden.

Rheumatology (Oxford) ; 2023 Oct 18.

Article en En | MEDLINE | ID: mdl-37851412

Palabras clave

Herpes Zoster; Janus Kinase inhibitors; Rheumatoid Arthritis; Vaccination; Vaccine immunogenicity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google